Notably, in large-scale screenings, GDF15 has been identified as the most significantly over-expressed soluble factor and its concentration is correlated with the progression in cancer patients across different cancer types, especially NSCLC (18). Here, GDF15 is linked to non-small cell lung carcinoma.